Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany.
Faculty of Physics and Center for NanoScience, Ludwig-Maximilians-Universität München, Munich, Germany.
PLoS One. 2019 Nov 20;14(11):e0224314. doi: 10.1371/journal.pone.0224314. eCollection 2019.
Cancer progression and metastases are frequently related to changes of cell motility. Amongst others, the microRNA-200c (miR-200c) was shown to maintain the epithelial state of cells and to hamper migration. Here, we describe two miR-200c inducible breast cancer cell lines, derived from miR-200c knock-out MCF7 cells as well as from the miR-200c-negative MDA-MB-231 cells and report on the emerging phenotypic effects after miR-200s induction. The induction of miR-200c expression seems to effect a rapid reduction of cell motility, as determined by 1D microlane migration assays. Sustained expression of miR200c leads to a changed morphology and reveals a novel mechanism by which miR-200c interferes with cytoskeletal components. We find that filamin A expression is attenuated by miRNA-200c induced downregulation of the transcription factors c-Jun and MRTF/SRF. This potentially novel pathway that is independent of the prominent ZEB axis could lead to a broader understanding of the role that miR200c plays in cancer metastasis.
癌症的进展和转移通常与细胞迁移能力的变化有关。其中,microRNA-200c(miR-200c)被证明可以维持细胞的上皮状态,并阻碍迁移。在这里,我们描述了两种可诱导表达 miR-200c 的乳腺癌细胞系,分别来源于 miR-200c 敲除的 MCF7 细胞和 miR-200c 阴性的 MDA-MB-231 细胞,并报告了 miR-200s 诱导后出现的表型效应。miR-200c 表达的诱导似乎会迅速降低细胞迁移能力,这可以通过 1D 微槽迁移实验来确定。持续表达 miR200c 导致形态发生改变,并揭示了 miR-200c 通过干扰细胞骨架成分来发挥作用的新机制。我们发现,miRNA-200c 诱导的转录因子 c-Jun 和 MRTF/SRF 的下调会减弱细丝蛋白 A 的表达。这种潜在的新途径可能独立于突出的 ZEB 轴,从而更全面地了解 miR200c 在癌症转移中的作用。